Swiss National Bank Has $411.42 Million Position in Stryker Corporation $SYK

Swiss National Bank boosted its stake in Stryker Corporation (NYSE:SYK) by 7.5% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,039,900 shares of the medical technology company’s stock after purchasing an additional 72,300 shares during the quarter. Swiss National Bank owned about 0.27% of Stryker worth $411,416,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in SYK. Mid American Wealth Advisory Group Inc. bought a new stake in shares of Stryker during the 2nd quarter worth $26,000. Sachetta LLC boosted its holdings in shares of Stryker by 58.7% in the 2nd quarter. Sachetta LLC now owns 73 shares of the medical technology company’s stock worth $29,000 after purchasing an additional 27 shares in the last quarter. Ridgewood Investments LLC raised its holdings in shares of Stryker by 48.4% during the 2nd quarter. Ridgewood Investments LLC now owns 92 shares of the medical technology company’s stock valued at $36,000 after buying an additional 30 shares in the last quarter. Ransom Advisory Ltd purchased a new position in Stryker in the 1st quarter worth $37,000. Finally, MTM Investment Management LLC purchased a new position in shares of Stryker in the second quarter worth about $38,000. Hedge funds and other institutional investors own 77.09% of the company’s stock.

Insider Buying and Selling at Stryker

In other news, insider Viju Menon sold 500 shares of the firm’s stock in a transaction dated Monday, August 25th. The stock was sold at an average price of $390.61, for a total value of $195,305.00. Following the completion of the transaction, the insider directly owned 12,511 shares in the company, valued at $4,886,921.71. This trade represents a 3.84% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CAO William E. Berry, Jr. sold 1,953 shares of the business’s stock in a transaction on Friday, November 14th. The shares were sold at an average price of $365.49, for a total transaction of $713,801.97. Following the transaction, the chief accounting officer owned 2,833 shares of the company’s stock, valued at $1,035,433.17. This represents a 40.81% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 522,618 shares of company stock valued at $185,577,237 in the last ninety days. Company insiders own 5.90% of the company’s stock.

Analysts Set New Price Targets

SYK has been the subject of a number of recent analyst reports. Wall Street Zen raised Stryker from a “hold” rating to a “buy” rating in a research report on Saturday, October 18th. Wells Fargo & Company boosted their target price on shares of Stryker from $452.00 to $456.00 and gave the company an “overweight” rating in a research report on Friday, November 14th. Needham & Company LLC restated a “buy” rating and set a $448.00 target price on shares of Stryker in a research report on Friday, November 14th. Redburn Partners set a $420.00 price target on shares of Stryker in a report on Thursday, September 18th. Finally, Barclays raised their price target on Stryker from $443.00 to $453.00 and gave the company an “overweight” rating in a report on Wednesday, October 22nd. Thirteen analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to MarketBeat.com, Stryker currently has an average rating of “Moderate Buy” and an average price target of $434.37.

Stryker Stock Down 1.0%

NYSE SYK opened at $360.46 on Friday. The company has a quick ratio of 1.06, a current ratio of 1.78 and a debt-to-equity ratio of 0.70. Stryker Corporation has a 52 week low of $329.16 and a 52 week high of $406.19. The firm has a market capitalization of $137.85 billion, a price-to-earnings ratio of 47.74, a PEG ratio of 2.66 and a beta of 0.94. The company has a fifty day moving average of $369.68 and a two-hundred day moving average of $380.77.

Stryker (NYSE:SYK) last released its earnings results on Thursday, October 30th. The medical technology company reported $3.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.13 by $0.06. The firm had revenue of $6.06 billion during the quarter, compared to analyst estimates of $6.04 billion. Stryker had a net margin of 12.25% and a return on equity of 23.94%. The business’s revenue was up 10.2% on a year-over-year basis. During the same quarter last year, the business earned $2.87 EPS. Stryker has set its FY 2025 guidance at 13.500-13.600 EPS. On average, analysts predict that Stryker Corporation will post 13.47 earnings per share for the current year.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.